# Glaukos breaks ground on $80M R&D and manufacturing facility in Huntsville, Alabama

Glaukos Corporation broke ground on a new 200,000-square-foot research, development, and manufacturing facility in Huntsville, Alabama, with a planned investment of over $80 million.

- Type: New facility
- Announced: 2025-09-25
- Where: Huntsville, Alabama, United States
- Value: $80.0M
- Status: under construction
- Capacity: 200,000 square feet
- Products: ophthalmic pharmaceuticals, medical devices for glaucoma, corneal disorders, and retinal diseases
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Glaukos Corporation](https://endata.com/companies/39036.md)

## Sources

- [investors.glaukos.com](https://investors.glaukos.com/news/news-details/2025/Glaukos-Breaks-Ground-on-New-Research-Development-and-Manufacturing-Facility-in-Huntsville-Alabama/default.aspx), 2025-09-25: "We are proud to expand our U.S. footprint with the development of this new state-of-the-art facility to augment our current infrastructure and support our long-term growth plans"
- [investor.wedbush.com](https://investor.wedbush.com/wedbush/article/bizwire-2025-9-25-glaukos-breaks-ground-on-new-research-development-and-manufacturing-facility-in-huntsville-alabama), 2025-09-25: "We are proud to expand our U.S. footprint with the development of this new state-of-the-art facility to augment our current infrastructure and support our long-term growth plans"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.